- Home
- HIFS vs MGTX Comparison
HIFS vs MGTX Comparison
Compare HIFS & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HIFS | MGTX |
|---|---|---|
| Founded | 1834 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 643.0M | 579.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HIFS | MGTX |
|---|---|---|
| Price | $311.63 | $7.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $23.83 |
| AVG Volume (30 Days) | 57.3K | ★ 400.1K |
| Earning Date | 01-16-2026 | 03-12-2026 |
| Dividend Yield | ★ 0.81% | N/A |
| EPS Growth | ★ 92.69 | N/A |
| EPS | ★ 24.76 | N/A |
| Revenue | ★ $102,779,000.00 | $27,417,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $569.48 |
| P/E Ratio | $12.64 | ★ N/A |
| Revenue Growth | 56.85 | ★ 96.83 |
| 52 Week Low | $209.71 | $4.55 |
| 52 Week High | $338.00 | $9.73 |
Technical Indicators
Market Signals| Indicator | HIFS | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 53.76 | 45.64 |
| Support Level | $289.59 | $7.16 |
| Resistance Level | $338.00 | $7.70 |
| Average True Range (ATR) | 16.07 | 0.40 |
| MACD | -1.30 | -0.02 |
| Stochastic Oscillator | 51.25 | 26.72 |
Price Performance
Historical ComparisonAbout HIFS Hingham Institution for Savings
Hingham Institution for Savings is a savings bank based in Hingham, Massachusetts, and is involved in the business of residential and commercial real estate mortgage lending and also financial and banking services. The bank's financial services include personal checking accounts, personal mortgages, home equity lines of credit, money market accounts, savings accounts, certificates of deposit, and business checking accounts. Its lending portfolio mainly encompasses commercial real estate, residential owner-occupied real estate, and loans for the construction of residential real estate.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.